| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |